Non-dystrophic myotonia: 2-year clinical and patient reported outcomes.

Fullam, Timothy R; Chandrashekhar, Swathy; Farmakidis, Constantine; Jawdat, Omar; Pasnoor, Mamatha; Dimachkie, Mazen M; Statland, Jeffrey M

Fullam, Timothy R; Chandrashekhar, Swathy; Farmakidis, Constantine; Jawdat, Omar; Pasnoor, Mamatha; Dimachkie, Mazen M; Statland, Jeffrey M.

Affiliation

Fullam TR; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Chandrashekhar S; Department of Neurology, Brooke Army Medical Center, JBSA-Fort Sam, Houston, Texas, USA.
Farmakidis C; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Jawdat O; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Pasnoor M; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Dimachkie MM; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Statland JM; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.

Muscle Nerve ; 66(2): 148-158, 2022 08.

Article in En | MEDLINE | ID: mdl-35644941

Subject(s)
Key words

electrodiagnostic testing; genetic testing; myotonia congenita; neuromuscular disorder; quality of life

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Channelopathies / Myotonia / Myotonic Dystrophy / Myotonia Congenita Type of study: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Muscle Nerve Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google